Navigation Links
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Date:8/21/2007

ents should call their doctor right away if they experience worsening depression symptoms, unusual changes in behavior or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.

Cymbalta is not for everyone. Patients should not take Cymbalta if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril(R) (thioridazine) or have uncontrolled glaucoma. Patients should speak with their doctor about all medicines they are taking, including those for migraine, to avoid a potentially life-threatening condition. Patients should tell their doctor about their alcohol consumption, if they have liver disease, and about all of their medical conditions.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include:

-- For MDD: Nausea, dry mouth and constipation

-- For DPNP: Nausea, somnolence (sleepiness), dizziness and constipation

-- For GAD: Nausea, fatigue, dry mouth, somnolence (sleepiness) and

constipation

This is not a complete list of side effects.

For full Patient Information, visit http://www.cymbalta.com.

For full Prescribing Information, including Boxed Warning, visit http://www.cymbalta.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is
'/>"/>

SOURCE Eli Lilly and Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, ... quarter ended June 30, 2015 and provided a ... "The second quarter of 2015 and recent period ... said Paul Grint, M.D., President and CEO of ...
(Date:8/4/2015)... 4, 2015 HeartWare International, Inc . ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... President and Chief Executive Officer, Doug Godshall , ... Annual Growth Conference at 8:30 a.m. EDT on Thursday, ... 12-13, 2015 at the InterContinental Boston. A ...
(Date:8/4/2015)... SEATTLE , Aug. 4, 2015  Dr. ... Institute states the potential FDA approval of flibanserin, ... sets women and the treatment of decreased female ... women has many root causes and addressing libido ... is dangerous. ...
Breaking Medicine Technology:Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 3Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 4Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 5Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 6Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 7Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 8Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 9Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 10HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Prescribing Reference, Inc. (PRI) and AnswersMedia, LLC today ... resource for drug, health, and nutrition information that enables ... Patient Advisor ( www.MPRPatientAdvisor.com ) integrates ... database, trusted by healthcare practitioners for over 25 years ...
... 4, 2011 Halozyme Therapeutics, Inc. (Nasdaq: ... targeting the extracellular matrix , today announced it ... on Friday March 11, 2011 before the open of ... a conference call with the investment community at 8:00 ...
Cached Medicine Technology:MPR Launches Patient Advisor—A Drug and Health Information Resource for Consumers From the Trusted Source Healthcare Practitioners Rely On 2Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11 2
(Date:8/5/2015)... ... August 05, 2015 , ... "Art ... Ron Fugate invited employees to suggest ideas to add some fun and visual ... had the winning idea to transform toilets into works of art. Renew Life ...
(Date:8/5/2015)... ... August 05, 2015 , ... Jvion’s CEO, Shantanu Nigam ... Health IT & CIO Review. The designation is given to those leaders who are ... the success of Jvion and the firm’s clinical predictive analytic solutions. , A spokesperson ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... UK have just published updated guidelines for the management of malignant pleural mesothelioma. ... here to read the article. , The updated guidelines issued by the ...
(Date:8/5/2015)... ... August 05, 2015 , ... What language does a ... and unique “dictionary” of American idioms and other expressions that contain the name of ... and entertaining. This book contains about 2,000 such idioms, words, and expressions, for example, ...
(Date:8/5/2015)... AZ (PRWEB) , ... August 05, 2015 , ... Stelari ... Stelari is reinventing yoga wear with their new line, The Earth’s Song. Combining fashion ... street and into your workout. Inspired by the Australian Outback, this collection is sure ...
Breaking Medicine News(10 mins):Health News:Fantastic Team Spirit and Creativity Prevailed at Renew Life “Art de Toilettes” 2Health News:Jvion’s Shantanu Nigam Named One of the 21 Health IT Leaders to Know 2Health News:New Mesothelioma Treatment Guidelines Issued By European Researchers, According to Surviving Mesothelioma 2Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3
... According to researchers, a new type of insulin that ... diabetics have a respiratory infection or are exposed to ... in major markets for treatment of diabetes. It uses ... information is important for healthcare providers," Professor Philippe Camus ...
... nasal spray used to treat migraine headaches can be ... nasal spray zolmitriptan targets nerves that carry pain signals, ... College London said.// ,Cluster headaches are not as ... Researchers tested 92 patients with cluster headaches. In the ...
... have developed a technique to find out if metastasis from ... <br.,The research scientists at Washington University School of Medicine ... of whether melanoma of the eye might spread to the ... The scientists were also of the opinion that the molecular ...
... that South Asian men have more urinary problems than white ... ,The urology study that was conducted on over ... the urology journal BJU International, states that South Asian men ... less likely to seek help. ,The researchers explained ...
... people can be a common feature but could be prevented.Researchers ... many a times the simple practise of getting in and ... turn out to be a dangerous feature even with essential ... of the American Geriatrics Society, explains that the researchers were ...
... human faculties" increases dependence on others and reduces the ... researchers to "direct their efforts in bringing about a ... ,Equality can be generated by prevention, early detection, ... minds of affected children in productive efforts to enable ...
Cached Medicine News:Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 2Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 3Health News:Metastasis Of Ocular Melanoma To Liver Can Now Be Calculated 4Health News:South Asian Men Have More Urinary Problems Than White Men 2Health News:Common Falls In Bath Among Older Adults Can Be Prevented 2Health News:Common Falls In Bath Among Older Adults Can Be Prevented 3Health News:Autistic Children Need Sense of Equality: A.P.J. Abdul Kalam 2
Custom Pediatric Nebulizer Assembly W/Tubing...
... the age of 3 can choose either the ... same design principle applies to both:, ,Maximize ... aerosol output when the patient exhales using two ... to leave the nebulizer. The result is a ...
... optimum lung penetration for maximum therapeutic benefit. ... µ at 6-8 LPM. Latex-free components. Usable ... the world leader in airway management products, ... proven technology by offering top brands in ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
Medicine Products: